Given the crucial role of immune mechanisms in the pathogenesis of IBD as well as the regulatory functions of EZH2 on both innate and adaptive immune cells, we next investigated whether and how GSK343 treatment impacts colonic immune cell infiltrates. This evidence concerns the gene EZH2 and inflammatory bowel disease.